Company intelligence / Profile preview

DaVinci Virtual

Guilford, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

DaVinci Therapeutics is a virtual biotechnology company and a subsidiary of Inveniai, focused on the discovery and development of novel therapeutic antibodies and antibody-drug conjugates (ADCs). The company leverages Inveniai's AlphaMeld AI platform to identify high-probability targets and optimize drug candidates for complex diseases. Operating as a virtual entity, DaVinci Therapeutics utilizes a lean business model to advance its oncology-focused pipeline through strategic partnerships and outsourced development. The company's approach combines advanced data analytics with biological insights to accelerate the transition from target identification to clinical development.

Therapeutic areas: Oncology
Modalities: Antibody-drug conjugateMonoclonal antibody
Industry: Biotech

Partnerships

Inveniai

Beyond the preview

Go deeper on DaVinci Virtual.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DaVinci Virtual.

Explore the full profile